RMD three-lens brief
Evidence-based stock research on RMD. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 19.4pp over 30 days. · Trading at 9% of its 52-week range — deep in the lower band.
- Trading at 9% of its 52-week range — deep in the lower band.
- Underperforming SPY by 19.4pp over 30 days.
- Analyst mean target $270.60 — 30% above current (15 analysts).
- Debt-to-equity of 13.4 — balance-sheet-heavy.
RMD closed at $207.48 (+1.20%) as of 2026-05-04. Market cap: $30.23B. P/E (trailing) 20.0. Positives: analyst mean target $270.60 — 30% above current (15 analysts).. Concerns: trading at 9% of its 52-week range — deep in the lower band.; underperforming SPY by 19.4pp over 30 days.. Last quarter: Revenue $1.43B, net income $398.73M, free cash flow $1.42B.
Why three lenses on RMD, not one.
A single reasoning model has blind spots it doesn’t know about. We examine RMDacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/RMD" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath RMD brief"></iframe>